NPPA Seems Defunct, Issuing Order On Cancer Drug Sale After Intervention: Cipla’s Achin Gupta
CNBC-TV18 · 27 Oct 2026 · 3 min
Management interview of Cipla Ltd (CIPLA).
- Achin Gupta, MD & Global CEO, Cipla
Cipla stated that the government's move to rationalise trade margins on high-end oncology drugs aligns with broader efforts to make healthcare affordable. Management noted it is premature to assess whether this decision will have a positive or negative impact on the business. Since supply prices from manufacturers remain largely unchanged, the cap primarily affects providers such as hospitals rather than pharmaceutical manufacturers. Management also highlighted that domestic pharmaceutical players are well-positioned to continue expanding market share.